Acute bilateral simultaneous angle closure glaucoma after topiramate administration: A case report

被引：16

作者：

Chalam K.V. ^{[1
]}

Tillis T. ^{[1
]}

Syed F. ^{[1
]}

Agarwal S. ^{[1
]}

Brar V.S. ^{[1
]}

机构：

[1] Department of Ophthalmology, University of Florida-Jacksonville, Jacksonville, FL

来源：

Journal of Medical Case Reports | / 2卷 / 1期

关键词：

Migraine; Intraocular Pressure; Topiramate; Anterior Chamber; Idiopathic Intracranial Hypertension;

D O I：

10.1186/1752-1947-2-1

中图分类号：

学科分类号：

摘要：

Introduction: A case of severe acute bilateral angle closure glaucoma with complete visual loss after oral topiramate therapy. Case presentation: A 34 year-old woman developed bilateral severe visual loss 2 days after doubling the dosage of topiramate. Her best-corrected visual acuity (BCVA) was counting fingers in both eyes (OU). Intraocular pressures were 49 mm and 51 mm of Hg in right and left eyes respectively, with conjunctival chemosis, corneal edema, shallow anterior chamber and closed angles on gonioscopy. B-scan ultrasound revealed annular peripheral choroidal effusions in both eyes. Conclusion: Intraocular pressures and anterior chamber depth were normalized after discontinuation of topiramate and initiation of antiglaucoma therapy. Two weeks later, visual acuities improved to 20/25 in the right eye and 20/40 in the left eye. B-scan ultrasound showed resolution of choroidal effusion. Topiramate, an oral sulpha-derivative medication is known to cause ciliochoroidal effusions, which lead to forward rotation of the ciliary body and displacement of the lens-iris diaphragm, with resultant acute angle closure glaucoma and myopic shift. © 2008 Chalam et al; licensee BioMed Central Ltd.

引用

共 11 条

[1]

Banta J.T., Hoffman K., Budenz D.L., Ceballos E., Greenfield D.S., Presumed Topiramate-induced Bilateral Acute Angle-closure Glaucoma, Am J Ophthalmol, 132, pp. 112-114, (2001)

[2]

Levy J., Yagev R., Petrova A., Lifshitz T., Topiramate-induced bilateral angle-closure glaucoma, Can J Ophthalmol, 41, pp. 221-225, (2006)

[3]

Fraunfelder F.W., Fraunfelder F.T., Keates E.U., Topiramate-Associated Acute, Bilateral, Secondary Angle-Closure Glaucoma, Ophthalmology, 111, pp. 109-111, (2004)

[4]

Craig J.E., Ong T.J., Louis D.L., Wells J.M., Mechanism of Topiramate-induced Acute-onset Myopia and Angle Closure Glaucoma, Am J Ophthalmol, 137, pp. 193-195, (2004)

[5]

Medeiros F.A., Zhang X.Y., Bernd A.S., Weinreb R.N., Angle-Closure Glaucoma Associated With Ciliary Body Detachment in Patients Using Topiramate, Arch Ophthalmol, 121, pp. 282-285, (2003)

[6]

Silberstein S.D., Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial, Headache, 47, 2, pp. 170-180, (2007)

[7]

Eisenberg E., River Y., Shifrin A., Krivoy N., Antiepileptic drugs in the treatment of neuropathic pain, Drugs, 67, 9, pp. 1265-1289, (2007)

[8]

Raskin P., CAPSS-141 Study Group. Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects, Neurology, 63, 5, pp. 865-873, (2004)

[9]

Celebisoy N., Gokcay F., Sirin H., Akyurekli O., Treatment of idiopathic intracranial hypertension: Topiramate vs acetazolamide, on open-label study, Acta Neurol Scand, 116, 5, pp. 322-327, (2007)

[10]

Johnson B.A., Topiramate for Alcoholism Study Group. Topiramate for treating alcohol dependence: A randomized control trial, JAMA, 298, 14, pp. 1641-1651, (2007)

← 1 2 →